Hyperimmune Globulin Does Not Prevent Congenital CMV Infection
Cytomegalovirus hyperimmune globulin does not lower incidence of composite of congenital CMV infection, perinatal death in offspring
More Than Half of Personnel at LTCFs Fully Vaccinated for COVID-19
56.8 percent of HCP are fully vaccinated, with coverage higher for physicians and advanced practice providers than for nurses, aides
Report Questions Benefit of FDA Accelerated Approval Pathway
112 of the 253 authorized drugs have not been confirmed as clinically effective; 24 of these have been on market more than five years
Physician’s Briefing Weekly Coronavirus Roundup
U.S. Medical Debt High, but Varies Geographically
Debt higher in the South, in lowest income ZIP codes, and in states without Medicaid expansion
Israel Offers COVID-19 Booster Shots to Anyone Over 60
Announcement comes amid increasing infections and indications that the vaccine's efficacy fades over time
Racial/Ethnic Disparities Persist in Adult Vaccination Coverage
Socioeconomic differences in flu vaccine uptake narrowed for those aged 18 to 64 years, but racial/ethnic, SES differences persisted for ≥65s
Nearly 60 Percent of Adults Report Pain in Past Three Months
39.0 percent reported back pain, 36.5 percent reported lower-limb pain, 30.7 percent reported upper-limb pain
Five-Year Extended Hormone Therapy No Better in Breast Cancer
Findings compared with two years of extended adjuvant anastrozole in postmenopausal women with hormone-receptor-positive breast cancer
Most With Reaction to mRNA COVID-19 Vaccine Tolerate Second Dose
Most patients with immediate, potentially allergic reaction to Pfizer-BioNTech or Moderna mRNA COVID-19 vaccine tolerate second dose
